|
|
|
|
LEADER |
02847nmm a2200313 u 4500 |
001 |
EB000378976 |
003 |
EBX01000000000000000232028 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
130626 ||| eng |
020 |
|
|
|a 9783540732778
|
100 |
1 |
|
|a Berger, Dietmar P.
|e [editor]
|
245 |
0 |
0 |
|a Concise Manual of Hematology and Oncology
|h Elektronische Ressource
|c edited by Dietmar P. Berger, Monika Engelhardt, Hartmut Henß, Roland Mertelsmann
|
250 |
|
|
|a 1st ed. 2008
|
260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 2008, 2008
|
300 |
|
|
|a XXI, 1002 p
|b online resource
|
505 |
0 |
|
|a Principles of Medical Oncology -- Special Diagnostics -- Pharmacology and Pharmacotherapy -- Supportive Treatment -- Particular Treatment Procedures -- Hematology and Hemostasis -- Hematological Neoplasia -- Medical Oncology -- Hematological and Oncological Emergencies -- Standard Operating Procedures (SOP) -- Standardized Treatment Protocols
|
653 |
|
|
|a Hematology
|
653 |
|
|
|a Hematology
|
653 |
|
|
|a Oncology
|
653 |
|
|
|a Oncology
|
700 |
1 |
|
|a Engelhardt, Monika
|e [editor]
|
700 |
1 |
|
|a Henß, Hartmut
|e [editor]
|
700 |
1 |
|
|a Mertelsmann, Roland
|e [editor]
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-540-73277-8?nosfx=y
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 616.15
|
520 |
|
|
|a How Do We Treat? Hematology and Oncology have seen rapid progress and advances during recent years. Increased knowledge of tumor biology, epidemiology, molecular genetics, growth reg- lation, and cellular functions has led to novel therapeutic paradigms. Targeted trea- ment approaches, antibodies, immunotherapy, and other new techniques complement classic chemotherapy, radiotherapy, and surgery. Patients are increasingly well educated as web-based information on diagnostic and therapeutic options as well as quality ma- agement and tumor outcome data are readily available. In this dynamic and fast-paced environment, it is of central importance to base clinical decisions and medical practice on the best available evidence. Continuous quality ma- agement, with clinical process documentation, standardization, and evaluation, leads to improved patient care and long-term outcomes. For these reasons, we have started to systematically capture and evaluate data on diagnosis, treatment, and outcomes of p- tients with solid tumors and hematological neoplasms at the Freiburg University Med- cal Center. We have developed standard operating procedures, clinical pathways, and diagnostic and therapeutic processes, following the principles of “Good Clinical Pra- tice.” Tese processes (e.g., detailed protocols for chemotherapy application, treatment fowcharts, clinical pathways) are continuously tested and validated in clinical practice
|